Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary

Marco Cattaruzza1, Tomasz J Guzik, Wojciech Słodowski

  • 1Department of Cardiovascular Physiology, University of Göttingen, Göttingen, Germany.

Circulation Research
|September 18, 2004
PubMed

Insights

A specific gene variant (-786C/T SNP in the NOS-3 gene) is linked to coronary heart disease (CHD). The CC genotype impairs nitric oxide (NO) production, increasing atherosclerosis risk.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Biology
  • Atherosclerosis Research

Background:

  • Coronary heart disease (CHD) involves atherosclerosis, where endothelial nitric oxide (NO) plays a protective role.
  • Shear stress-mediated NO release is crucial for preventing atherosclerosis.
  • Polymorphisms in the endothelial NO synthase (NOS-3) gene may influence CHD development.

Purpose of the Study:

  • To investigate the functional impact of the -786C/T single nucleotide polymorphism (SNP) in the human NOS-3 gene on endothelial NO production.
  • To determine if this NOS-3 gene polymorphism is associated with coronary heart disease (CHD).

Main Methods:

  • Genotyping of endothelial cells and patient cohorts for the -786C/T NOS-3 SNP.
  • Analysis of NOS-3 mRNA and protein expression under shear stress conditions.
  • Assessment of NO-dependent vasodilation in saphenous vein grafts.
  • Quantitative coronary angiography in genotyped patients.

Main Results:

  • Shear stress-induced NOS-3 expression was observed in TT and CT genotypes but not in the CC genotype.
  • Decoy oligonucleotide treatment restored NOS-3 expression in CC cells.
  • NO-mediated relaxation was significantly reduced in vein grafts from CC genotype patients.
  • The CC genotype was significantly more prevalent in CHD-positive patients compared to CHD-negative controls.

Conclusions:

  • The -786C/T SNP in the NOS-3 gene is a genetic risk factor for CHD.
  • The CC genotype likely impairs shear stress-dependent NOS-3 expression, potentially by blocking transcription factor binding.
  • This genetic variation affects endothelial function and contributes to atherosclerosis development.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...